BCM
EXAS

BluePath Capital Management’s Exact Sciences EXAS Stock Holding History

BluePath Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-477
Closed -$32.5K – 177
2023
Q3 		$32.5K Buy
+477
New +$40.5K 0.03% 246

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BluePath Capital Management's EXAS Position: Q4 2023 in Review

BluePath Capital Management sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 477 shares — an estimated $32.5K sold.

BluePath Capital Management first reported a position in EXAS in Q3 2023 and held it in 1 quarter. The position peaked at $32.5K in Q3 2023. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • BluePath Capital Management reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • BluePath Capital Management sold 477 Exact Sciences shares in Q4 2023, an estimated $32.5K.
  • BluePath Capital Management first reported a position in Exact Sciences in Q3 2023 and held it in 1 quarter.
  • BluePath Capital Management's Exact Sciences position peaked at $32.5K in Q3 2023.
  • 647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on BluePath Capital Management's 13F filing for Q4 2023, filed 11 Jan 2024.